It’s hard to think of an aspect of health care more vexing than prior authorizations. In fact, prior authorizations are so frustrating that Congress is looking into a legislative solution.
This episode of The IDI we have two guests to explain the state of prior authorization and how to improve the process.
John Hennessy is a principal with Valuate Health with a background in oncology and cancer care.
Syam Palakurthy is co-founder and CEO of SamaCare, a company that streamlines the prior authorization process for medical benefit drugs.
Follow Valuate on LinkedIn.
10/02/23 • 30 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-idi-412997/why-prior-authorization-matters-for-pharma-57509687"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to why prior authorization matters for pharma on goodpods" style="width: 225px" /> </a>
Copy